Vijaya Vemulakonda
Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urologic Surgical Procedures | 14 | 2022 | 94 | 3.990 |
Why?
| Ureteral Obstruction | 6 | 2021 | 54 | 3.510 |
Why?
| Hydronephrosis | 6 | 2021 | 28 | 2.800 |
Why?
| Urology | 6 | 2019 | 50 | 2.060 |
Why?
| Electronic Health Records | 6 | 2022 | 805 | 1.810 |
Why?
| Urinary Bladder | 6 | 2022 | 165 | 1.750 |
Why?
| Kidney Pelvis | 3 | 2021 | 20 | 1.720 |
Why?
| Fetal Diseases | 2 | 2022 | 148 | 1.520 |
Why?
| Renal Insufficiency | 2 | 2023 | 137 | 1.490 |
Why?
| Vesico-Ureteral Reflux | 3 | 2022 | 22 | 1.360 |
Why?
| Kidney | 5 | 2023 | 1207 | 1.190 |
Why?
| Infant | 23 | 2023 | 7976 | 1.130 |
Why?
| Pediatrics | 4 | 2019 | 986 | 1.090 |
Why?
| Urethral Diseases | 3 | 2022 | 18 | 1.030 |
Why?
| Decision Making | 2 | 2023 | 791 | 0.960 |
Why?
| Urologists | 2 | 2020 | 17 | 0.830 |
Why?
| Amniotic Fluid | 1 | 2022 | 64 | 0.830 |
Why?
| Urethral Obstruction | 1 | 2022 | 9 | 0.820 |
Why?
| Child | 31 | 2023 | 18487 | 0.800 |
Why?
| Urinary Tract | 1 | 2022 | 37 | 0.800 |
Why?
| Urinary Tract Infections | 3 | 2022 | 136 | 0.790 |
Why?
| Urologic Diseases | 3 | 2018 | 36 | 0.760 |
Why?
| Qualitative Research | 5 | 2022 | 975 | 0.750 |
Why?
| Multicystic Dysplastic Kidney | 1 | 2020 | 3 | 0.750 |
Why?
| Ultrasonography, Prenatal | 5 | 2022 | 235 | 0.740 |
Why?
| Kidney Transplantation | 2 | 2022 | 558 | 0.740 |
Why?
| Kidney Diseases, Cystic | 1 | 2020 | 20 | 0.740 |
Why?
| Urinary Bladder, Neurogenic | 5 | 2022 | 30 | 0.720 |
Why?
| Hypospadias | 2 | 2018 | 26 | 0.720 |
Why?
| Documentation | 1 | 2022 | 169 | 0.720 |
Why?
| Biomedical Research | 2 | 2018 | 588 | 0.720 |
Why?
| Practice Patterns, Physicians' | 3 | 2020 | 1180 | 0.680 |
Why?
| Fasting | 1 | 2020 | 241 | 0.640 |
Why?
| Humans | 52 | 2023 | 115613 | 0.640 |
Why?
| Neurotoxicity Syndromes | 1 | 2018 | 14 | 0.640 |
Why?
| Parents | 3 | 2023 | 1207 | 0.630 |
Why?
| Stakeholder Participation | 1 | 2019 | 73 | 0.620 |
Why?
| Urinary Incontinence | 2 | 2016 | 58 | 0.610 |
Why?
| Preoperative Care | 1 | 2020 | 318 | 0.610 |
Why?
| Postnatal Care | 2 | 2015 | 67 | 0.600 |
Why?
| Urinary Fistula | 1 | 2017 | 9 | 0.580 |
Why?
| Prenatal Diagnosis | 2 | 2020 | 167 | 0.570 |
Why?
| Outpatients | 1 | 2020 | 330 | 0.570 |
Why?
| Anesthesia | 1 | 2018 | 119 | 0.560 |
Why?
| Child, Preschool | 16 | 2023 | 9131 | 0.550 |
Why?
| Epispadias | 1 | 2016 | 3 | 0.550 |
Why?
| Kidney Failure, Chronic | 1 | 2022 | 490 | 0.550 |
Why?
| Clinical Decision-Making | 1 | 2019 | 273 | 0.550 |
Why?
| Bladder Exstrophy | 1 | 2016 | 16 | 0.550 |
Why?
| Urogenital Surgical Procedures | 1 | 2016 | 5 | 0.550 |
Why?
| Intermittent Urethral Catheterization | 1 | 2016 | 3 | 0.540 |
Why?
| Urogenital System | 1 | 2016 | 18 | 0.540 |
Why?
| Spinal Dysraphism | 2 | 2017 | 43 | 0.540 |
Why?
| Appointments and Schedules | 2 | 2014 | 74 | 0.510 |
Why?
| Retrospective Studies | 18 | 2023 | 12608 | 0.500 |
Why?
| Female | 31 | 2023 | 59932 | 0.500 |
Why?
| Cultural Diversity | 2 | 2022 | 55 | 0.500 |
Why?
| Urinary Bladder Neoplasms | 2 | 2008 | 197 | 0.500 |
Why?
| Risk Assessment | 4 | 2018 | 2987 | 0.490 |
Why?
| Hernia, Umbilical | 1 | 2014 | 17 | 0.450 |
Why?
| Anus, Imperforate | 1 | 2014 | 22 | 0.450 |
Why?
| Infant, Newborn | 8 | 2022 | 5060 | 0.450 |
Why?
| Urethra | 1 | 2014 | 49 | 0.440 |
Why?
| Urogenital Abnormalities | 1 | 2014 | 48 | 0.440 |
Why?
| Referral and Consultation | 1 | 2017 | 646 | 0.420 |
Why?
| Tumor Burden | 1 | 2013 | 261 | 0.420 |
Why?
| Wilms Tumor | 1 | 2013 | 66 | 0.420 |
Why?
| Ambulatory Surgical Procedures | 1 | 2012 | 48 | 0.400 |
Why?
| Physicians | 1 | 2020 | 776 | 0.400 |
Why?
| Patient Selection | 1 | 2015 | 654 | 0.390 |
Why?
| Botulinum Toxins, Type A | 3 | 2011 | 40 | 0.390 |
Why?
| Scoliosis | 1 | 2014 | 181 | 0.380 |
Why?
| Data Collection | 1 | 2014 | 636 | 0.380 |
Why?
| Male | 27 | 2023 | 55968 | 0.380 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2015 | 1218 | 0.350 |
Why?
| Pregnancy | 4 | 2022 | 5550 | 0.350 |
Why?
| Ultrasonography | 3 | 2021 | 642 | 0.330 |
Why?
| Tertiary Care Centers | 3 | 2019 | 127 | 0.330 |
Why?
| Dextrans | 1 | 2009 | 74 | 0.320 |
Why?
| Cystitis | 2 | 2005 | 20 | 0.310 |
Why?
| Internship and Residency | 2 | 2008 | 951 | 0.310 |
Why?
| Prune Belly Syndrome | 1 | 2007 | 7 | 0.300 |
Why?
| Follow-Up Studies | 6 | 2019 | 4440 | 0.300 |
Why?
| Stomach Neoplasms | 1 | 2008 | 66 | 0.290 |
Why?
| Ethics, Professional | 1 | 2007 | 15 | 0.290 |
Why?
| Hyaluronic Acid | 1 | 2009 | 190 | 0.290 |
Why?
| Diurnal Enuresis | 1 | 2006 | 1 | 0.280 |
Why?
| Competency-Based Education | 1 | 2007 | 66 | 0.280 |
Why?
| Adolescent | 11 | 2023 | 17903 | 0.280 |
Why?
| Professional Competence | 1 | 2007 | 86 | 0.280 |
Why?
| Databases, Factual | 3 | 2022 | 1138 | 0.270 |
Why?
| Adenoma | 1 | 2007 | 187 | 0.260 |
Why?
| Feasibility Studies | 2 | 2022 | 741 | 0.260 |
Why?
| Biocompatible Materials | 1 | 2009 | 378 | 0.250 |
Why?
| Neuromuscular Agents | 1 | 2005 | 30 | 0.240 |
Why?
| Postoperative Complications | 4 | 2020 | 2161 | 0.240 |
Why?
| Education, Medical, Graduate | 1 | 2008 | 376 | 0.230 |
Why?
| Dissent and Disputes | 1 | 2023 | 18 | 0.230 |
Why?
| Incidence | 3 | 2018 | 2335 | 0.220 |
Why?
| Prospective Studies | 4 | 2020 | 6264 | 0.220 |
Why?
| Muscle, Smooth | 2 | 2022 | 150 | 0.210 |
Why?
| Patient Care | 1 | 2023 | 103 | 0.210 |
Why?
| Urinary Bladder Diseases | 1 | 2022 | 19 | 0.210 |
Why?
| Laparoscopy | 2 | 2022 | 400 | 0.210 |
Why?
| Duodenum | 1 | 2022 | 63 | 0.210 |
Why?
| Neoplasm Recurrence, Local | 1 | 2007 | 863 | 0.210 |
Why?
| Registries | 2 | 2022 | 1770 | 0.200 |
Why?
| Sexual Development | 1 | 2022 | 19 | 0.200 |
Why?
| Postoperative Period | 2 | 2020 | 292 | 0.200 |
Why?
| Social Justice | 1 | 2022 | 66 | 0.200 |
Why?
| Ureter | 1 | 2022 | 31 | 0.200 |
Why?
| Probability | 1 | 2022 | 294 | 0.200 |
Why?
| Urination | 3 | 2014 | 40 | 0.200 |
Why?
| Injury Severity Score | 1 | 2023 | 458 | 0.200 |
Why?
| Renal Replacement Therapy | 1 | 2022 | 68 | 0.200 |
Why?
| Clinical Competence | 1 | 2008 | 912 | 0.190 |
Why?
| Trauma Centers | 1 | 2023 | 329 | 0.190 |
Why?
| Adenocarcinoma | 1 | 2008 | 799 | 0.190 |
Why?
| Urography | 2 | 2014 | 13 | 0.190 |
Why?
| Wounds, Nonpenetrating | 1 | 2023 | 225 | 0.190 |
Why?
| Ambulatory Care Facilities | 1 | 2022 | 211 | 0.180 |
Why?
| Actins | 1 | 2022 | 383 | 0.180 |
Why?
| United States | 6 | 2023 | 12297 | 0.170 |
Why?
| Ambulatory Care | 2 | 2022 | 479 | 0.170 |
Why?
| Patient Portals | 1 | 2019 | 34 | 0.160 |
Why?
| User-Computer Interface | 1 | 2019 | 145 | 0.160 |
Why?
| Bacteriuria | 1 | 2018 | 8 | 0.160 |
Why?
| Renal Dialysis | 1 | 2022 | 369 | 0.150 |
Why?
| Social Support | 1 | 2022 | 539 | 0.150 |
Why?
| Urologic Surgical Procedures, Male | 1 | 2018 | 27 | 0.150 |
Why?
| Disorders of Sex Development | 1 | 2018 | 35 | 0.150 |
Why?
| Cohort Studies | 3 | 2017 | 4945 | 0.150 |
Why?
| Cystostomy | 1 | 2017 | 8 | 0.150 |
Why?
| Treatment Outcome | 4 | 2021 | 9159 | 0.140 |
Why?
| Hospitals, Pediatric | 1 | 2020 | 478 | 0.140 |
Why?
| Perioperative Care | 1 | 2018 | 126 | 0.140 |
Why?
| Fetus | 1 | 2020 | 702 | 0.140 |
Why?
| Analgesia | 1 | 2017 | 82 | 0.140 |
Why?
| Surveys and Questionnaires | 3 | 2022 | 4668 | 0.140 |
Why?
| Genital Diseases, Male | 1 | 2016 | 15 | 0.140 |
Why?
| Global Health | 1 | 2018 | 290 | 0.130 |
Why?
| Adult | 7 | 2022 | 30726 | 0.130 |
Why?
| Reoperation | 1 | 2018 | 525 | 0.130 |
Why?
| Caregivers | 1 | 2022 | 716 | 0.130 |
Why?
| Risk Factors | 5 | 2018 | 8699 | 0.130 |
Why?
| General Surgery | 1 | 2016 | 129 | 0.120 |
Why?
| Recovery of Function | 1 | 2018 | 577 | 0.120 |
Why?
| Health Information Exchange | 1 | 2014 | 11 | 0.110 |
Why?
| ROC Curve | 1 | 2015 | 451 | 0.110 |
Why?
| Age Factors | 3 | 2018 | 2907 | 0.110 |
Why?
| Cloaca | 1 | 2014 | 48 | 0.110 |
Why?
| Program Evaluation | 2 | 2008 | 836 | 0.110 |
Why?
| Cystoscopy | 2 | 2011 | 16 | 0.100 |
Why?
| Sex Factors | 3 | 2018 | 1737 | 0.100 |
Why?
| Urinary Retention | 1 | 2011 | 19 | 0.090 |
Why?
| Diagnostic Imaging | 1 | 2014 | 296 | 0.090 |
Why?
| Severity of Illness Index | 2 | 2015 | 2578 | 0.090 |
Why?
| Patient Compliance | 1 | 2014 | 524 | 0.090 |
Why?
| Length of Stay | 2 | 2018 | 958 | 0.080 |
Why?
| Ureteroscopy | 1 | 2009 | 16 | 0.080 |
Why?
| Injections | 1 | 2009 | 161 | 0.080 |
Why?
| Reproducibility of Results | 1 | 2015 | 2800 | 0.080 |
Why?
| Electrocoagulation | 1 | 2007 | 38 | 0.070 |
Why?
| Stomach | 1 | 2008 | 101 | 0.070 |
Why?
| Anastomosis, Surgical | 1 | 2008 | 140 | 0.070 |
Why?
| Medical Staff, Hospital | 1 | 2007 | 74 | 0.070 |
Why?
| Educational Measurement | 1 | 2008 | 262 | 0.070 |
Why?
| Professional Role | 1 | 2007 | 153 | 0.060 |
Why?
| Urothelium | 1 | 2005 | 33 | 0.060 |
Why?
| Administration, Intravesical | 1 | 2005 | 14 | 0.060 |
Why?
| Program Development | 1 | 2007 | 350 | 0.060 |
Why?
| Faculty, Medical | 1 | 2007 | 234 | 0.060 |
Why?
| Colorado | 1 | 2014 | 4116 | 0.060 |
Why?
| Biomarkers | 1 | 2014 | 3468 | 0.060 |
Why?
| Biopsy | 1 | 2007 | 1056 | 0.060 |
Why?
| Tomography, X-Ray Computed | 1 | 2013 | 2392 | 0.060 |
Why?
| Phimosis | 1 | 2003 | 1 | 0.060 |
Why?
| Circumcision, Male | 1 | 2003 | 17 | 0.050 |
Why?
| Adenosine Triphosphate | 1 | 2005 | 431 | 0.050 |
Why?
| Rats, Sprague-Dawley | 2 | 2005 | 2262 | 0.050 |
Why?
| Magnetic Resonance Imaging | 1 | 2014 | 3071 | 0.050 |
Why?
| Disease Management | 1 | 2006 | 563 | 0.050 |
Why?
| Chronic Disease | 2 | 2005 | 1598 | 0.050 |
Why?
| Advisory Committees | 1 | 2022 | 208 | 0.050 |
Why?
| Rats | 2 | 2005 | 5034 | 0.040 |
Why?
| Cryptorchidism | 1 | 2018 | 11 | 0.040 |
Why?
| Urolithiasis | 1 | 2018 | 8 | 0.040 |
Why?
| Intraoperative Period | 1 | 2018 | 50 | 0.040 |
Why?
| Stents | 1 | 2022 | 475 | 0.040 |
Why?
| Colony Count, Microbial | 1 | 2018 | 112 | 0.040 |
Why?
| Urine | 1 | 2018 | 56 | 0.040 |
Why?
| Constipation | 1 | 2018 | 75 | 0.040 |
Why?
| Young Adult | 2 | 2022 | 10487 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2018 | 1440 | 0.030 |
Why?
| Logistic Models | 1 | 2018 | 1856 | 0.030 |
Why?
| Quality Improvement | 1 | 2020 | 958 | 0.030 |
Why?
| Information Storage and Retrieval | 1 | 2014 | 109 | 0.030 |
Why?
| Anti-Bacterial Agents | 1 | 2022 | 1485 | 0.030 |
Why?
| Quality of Life | 1 | 2022 | 2387 | 0.020 |
Why?
| Injections, Intralesional | 1 | 2011 | 32 | 0.020 |
Why?
| Case-Control Studies | 1 | 2018 | 3023 | 0.020 |
Why?
| Urodynamics | 1 | 2011 | 28 | 0.020 |
Why?
| Lower Urinary Tract Symptoms | 1 | 2011 | 47 | 0.020 |
Why?
| Prognosis | 1 | 2018 | 3339 | 0.020 |
Why?
| Behavior Therapy | 1 | 2011 | 225 | 0.020 |
Why?
| Drug Therapy, Combination | 1 | 2011 | 962 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2011 | 1127 | 0.020 |
Why?
| Physical Therapy Modalities | 1 | 2011 | 269 | 0.020 |
Why?
| Animals | 2 | 2005 | 32102 | 0.020 |
Why?
| Time Factors | 1 | 2017 | 6165 | 0.020 |
Why?
| Nerve Fibers, Unmyelinated | 1 | 2005 | 9 | 0.020 |
Why?
| Mechanoreceptors | 1 | 2005 | 12 | 0.020 |
Why?
| Osmotic Pressure | 1 | 2005 | 28 | 0.020 |
Why?
| Physical Stimulation | 1 | 2005 | 78 | 0.020 |
Why?
| Cyclophosphamide | 1 | 2005 | 218 | 0.020 |
Why?
| Sensory Receptor Cells | 1 | 2005 | 78 | 0.020 |
Why?
| Muscle Contraction | 1 | 2005 | 397 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2005 | 3580 | 0.010 |
Why?
|
|
Vemulakonda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|